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It has been shown that there are many Chinese traditional herbals that can enhance sexual activity.
Chuanxiongzine is a vasoactive ingredient that has been isolated and purified from Ligusticum
chuanxiong Hort. In previous studies, it has been found that chuanxiongzine was effective in
relaxing rabbit corpus cavernosum smooth muscle. We determined the effects of chuanxiongzine
on relaxation of isolated corpus cavernosum strips in vitro and on increase of intracavernous
pressure (ICP) in vivo in rabbits. Chuanxiongzine caused a concentration-dependent relaxation of
phenylephrine precontracted isolated corpus cavernosum strips (EC50 1.58 10
 4moll
 1), which
were endothelium independent and NO independent. However, the guanylyl cyclase inhibitor
1-H-[1,2,4] oxadiazolo [4,3-a] quinoxalin-1-one significantly shifted the chuanxiongzine concentra-
tion–response relationship to the right. Although there was no significant difference in the level of
cyclic guanosine monophosphate (cGMP) and cyclic adenosine monophosphate (cAMP) in isolated
corpus cavernosum strips treated with chuanxiongzine or vehicle, chuanxiongzine caused a
significant rise in the level of cGMP and cAMP in isolated corpus cavernosum strips pretreated with
the activator of adenylyl cyclase forskolin and the source of NO sodium nitroprusside. In an in vivo
study, chuanxiongzine dose-dependently raised ICP after the intracavernous injection of its
cumulative doses (0.5, 1, 2 and 5mgkg
 1). The ICP increased from baseline to 19.1±3.7, 24.8±2.1,
30.2±4.8 and 39.7±6.1mmHg, respectively, and the duration of tumescence ranged from 8.5±2.8
to 22.9±7.3min. Our results show that chuanxiongzine can relax isolated corpus cavernosum strips
of rabbits in vitro and increase ICP of rabbits in vivo, which is neither endothelium dependent
nor NO dependent, but may be partly mediated by the inhibition of cAMP phosphodiesterase or
cGMP phosphodiesterase.
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Introduction
Erectile dysfunction is a common disorder affecting
millions of the aged men worldwide. Feldman et al.
1
have reported that men aged 40–70 years suffered
from ED of various degrees by approximately 50%.
Current pharmacological treatment for ED includes
the oral, intracavernosal and intraurethral adminis-
tration of erectogenic drugs.
2–6 It has been proved
that penile erection depends highly on the relaxa-
tion of penile arteries and erectile tissue such as the
corpus cavernosum smooth muscle.
7–10 Some drugs
such as inhibitors of PDE5 or other vasodilators,
which can promote the relaxation of corpus caver-
nosum smooth muscle, can be potentially used to
treat ED.
11–19 It has been shown that there are many
Chinese traditional herbals that can enhance sexual
activity.
20–24 Recently, there is an increasing interest
in investigating their effective components.
Chuanxiongzine is a vasoactive ingredient that
has been isolated and purified from Ligusticum
chuanxiong Hort (Umbelliferae) and is behind an
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www.nature.com/ijirancient Chinese herbal remedy. Owing to its
vasodilatory actions, chuanxiongzine has been
used for the treatment of a variety of vascular
diseases such as pulmonary hypertension secondary
to chronic obstructive pulmonary disease.
25 In
previous studies, it has been found that chuan-
xiongzine was effective in relaxing rabbit corpus
cavernosum smooth muscle.
26 However, the
relaxant effect of chuanxiongzine on cavernosal
strips and its mechanism have not been fully
elucidated. This study aims to investigate if chuan-
xiongzine can relax isolated corpus cavernosum
strips in vitro and increase intracavernous pressure
(ICP) in vivo. We report here that chuanxiongzine
may improve the relaxation of isolated corpus
cavernosum strips and enhance ICP through an
increase in the levels of cyclic adenosine mono-
phosphate (cAMP) and cyclic guanosine monophos-
phate (cGMP).
Materials and methods
Cavernosal tissue strips preparation
All animal experiments were carried out with the
approval of the Institute for Animal Care and Use
Committee of Tongji Hospital (Wuhan, China).
Twenty sexually mature male New Zealand white
rabbits (3.2±0.3kg) were anesthetized by subcuta-
neously injecting xylazine (5mgkg
 1)a n dk e t a -
mine (20mgkg
 1, i.m.) into the ear vein. Subse-
quently, the entire penis was surgically excised and
cleaned by removing the corpus spongiosum and
urethra. Then it was immediately immersed in an
organ chamber containing fresh 41C Krebs solution
and the corpus cavernosum tissue was carefully
dissected away from the surrounding tunica.
27,28
Three to four cavernosal strips of approximately equal
size (2 2 8mm) were obtained from each penis
and were prepared for organ bath studies separately.
Each cavernosal strip was tied with silk in one organ
chamber with one end fixed to a tissue holder and
the other secured to a force transducer. The latter
was connected to an appropriately calibrated four-
channel polygraph (PowerLab; ADInstruments,Sydney,
Australia) in which the transducer output was
recorded. Cavernosal strips were maintained in the
organ baths with Krebs solution at 371Cb ya
thermoregulated water circuit and by continuously
bubbling with a mixture of 95% O2 and 5% CO2
during the study. Each cavernosal strip was
stretched to an optimal isometric tension of 2.0g,
which was previously found to be optimal for
measurement of changes in the tension of rabbit
corpus cavernosal preparation and was equilibrated
for 2h. During the equilibration period, the tissues
were washed out with fresh Krebs solution every
15min and tension was adjusted, if necessary.
Drugs and solutions
The following drugs were tested: chuanxiongzine
hydrochloride was obtained from the National
Institute for the Control of Pharmaceutical and
Biological Products. N
G-nitro-L-arginine methyl
ester (L-NAME), 1-H-[1,2,4] oxadiazolo [4,3-a] qui-
noxalin-1-one (ODQ), forskolin and sodium nitro-
prusside were purchased from Sigma Chemical
Company (St Louis, MO, USA). The composition
of Krebs solution was as follows: (mmoll
 1) NaCl
119, KCl 4.7, MgCl2 1.2, CaCl2 2.5, NaHCO3 15,
NaH2PO4 1.2, glucose 11 (pH 7.4).
Organ bath studies in vitro
A1 0
 5moll
 1 phenylephrine (PE) was added to
each organ bath containing cavernosal strips at
optimal isometric resting tension after they were
equilibrated for 2h. Subsequently, PE resulted in
cavernosal strips contraction and rapidly reached a
steady state of active tension. When a steady state of
contraction was achieved, cumulative drug vehicle
doses (control) were added to each organ bath and
dose–responses were recorded on the polygraph.
Although the strips showed no more changes of
tension in response to vehicle, they were washed
out three times. After washout and reequilibration
for 1h, the same PE concentration (10
 5moll
 1) was
added to induce cavernosal strips contraction.
Similarly, cumulative doses (10
 8 to 10
 4moll
 1)
of chuanxiongzine were added to each organ bath
and dose–responses were recorded.
The role of endothelium and NO was determined
in endothelium-denuded isolated corpus caverno-
sum strips following incubation of the NO synthase
inhibitor L-NAME. The role of cAMP was investi-
gated in the presence of the guanylyl cyclase
inhibitor ODQ. In the denuded endothelium group,
the corporal cavernosum strips were removed and
tested for functionally deprived endothelium. If
they reacted poorly (o10% of maximal relaxation)
to acetylcholine (10
 5moll
 1) in the tissues with
endothelium removed, they were considered to be
successfully denuded of endothelium and were
used for this study.
29
Influence of the level of cAMP and cGMP by
chuanxiongzine
The denuded endothelium cavernosal strips were
suspended in organ baths and equilibrated for 2h.
Chuanxiongzine (10
 4moll
 1) and vehicle were
added to organ baths without the precontraction by
PE. In another group, a PE-induced contraction was
obtained as described above, and chuanxiongzine
(10
 4moll
 1) and vehicle were added. When they
were in a steady state, the tissues were immediately
frozen in liquid nitrogen for further study of cAMP
and cGMP levels. The test was repeated with the
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with the guanylyl cyclase activator forskolin
(10
 6moll
 1) and the NO supplier sodium nitroprus-
side (10
 6moll
 1), respectively, to increase the level
of cAMP and cGMP.
cAMP and cGMP levels in corpus cavernosum
were measured by
125I radioimmunoassay (Isotope
Unit, Shanghai University of Chinese Medicine)
according to the manufacturer’s protocol. Briefly, the
frozen 50mg cavernosal tissue was homogenized
with a microhomogenizer in 2ml of acetate acid
buffer. After centrifugation, the supernatant was
extracted with water-saturated diethyl ether, and
aliquots of the aqueous phase were lyophilized to
dryness at 601C bathwater. The 100ml samples were
mixed with 5ml acetylate, 100ml
125I, 100ml anti-
serum and kept at 41C overnight. Subsequently,
100ml rabbit serum and 100ml goat anti-rabbit IgG,
respectively, were added into the samples. They
were then incubated fully at 41C overnight. On the
following day, the samples were centrifuged at
3000r.p.m. for 15min. The supernatant was dis-
carded, and then the g
  radioactive intensity was
measured. Finally, the contents of cGMP and cAMP
in the samples were obtained according to a
designed standard curve.
In vivo studies
Twelve mature male New Zealand white rabbits
weighing 3.2±0.3kg were used for in vivo studies.
They were anesthetized with intraperitoneal pento-
barbital sodium (30mgkg
 1) and maintained
(10mgkg
 1) as needed. Animals were secured in
the supine position and the common carotid artery
on one side was exposed through a midline neck
incision and cannulated for continuous monitoring
of systolic arterial pressure (SAP), mean blood
pressure (MBp) and heart rate (HR) through an
ML0380 pressure transducer on a PowerLab poly-
graph. A 25-gauge needle filled with heparinized
saline was inserted into the corpus cavernosum
for ICP measuring through the MLT844 pressure
transducer. The needle was connected to a three-
way stopcock to administrate by intracavernosal
injection. All the tubes were filled with heparinized
saline to prevent clotting. Increasing concentrations
of chuanxiongzine (0.5–5mgkg
 1) were injected
intracavernosally in seven rabbits with the highest
volume of less than 0.15ml and normal saline
of the same volume was administrated in five
rabbits as a control group. ICP, duration of tumes-
cence (DT) and SAP were recorded after the
intracavernosal administration of cumulative
doses of chuanxiongzine and the same volume of
normal saline. To minimize the effect of the
previous drug, we washed the cavernous body with
0.15ml normal saline before each injection and




All data were expressed as mean±s.e.m.
(standard error of mean). The relaxatory response
induced by cumulative concentration of chuan-
xiongzine was expressed as the percentage of
inhibitions of the initial tension of isolated corpus
cavernosum strips induced by PE. The erectile
responses were normalized by calculating the
ratio of ICP/SAP because ICP was ultimately
limited by SAP in vivo.
31 Statistical significance
was evaluated by Student’s t-test. Statistical sig-
nificance between different groups was analyzed
by analysis of variance by means of SPSS 12.0
software (SPSS Inc., Chicago, IL, USA). EC50 values
as the concentrations at which 50% relaxation
occurred were calculated by using nonlinear curve
fitting software (PHARM/PCS version 4.2, Springer-
Verlag, New York, NY, USA). Results were consi-
dered as significant at Po0.05.
Results
Relaxatory response of isolated cavernosal strips by
chuanxiongzine in vitro
Chuanxiongzine caused a concentration-dependent
relaxation of isolated rabbit cavernosal strips
precontracted with PE (Figure 1, EC50 1.58 
10
 4moll
 1, Po0.05 when compared with the
vehicle). The presence of L-NAME or removal
of endothelium had no significant effect on chuan-
xiongzine-induced relaxation in them, but the
presence of ODQ caused a significant shift to the



































Figure 1 Chuanxiongzine-induced relaxation in isolated corpus
cavernosum strips precontracted with 10
 5moll
 1 phenylephrine.
Symbols are mean±s.e.m. *Po0.05, when compared with that by
the vehicle.
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and cGMP
Without forskolin and sodium nitroprusside, the
contents of cAMP and cGMP were measured in
response to chuanxiongzine (10
 4moll
 1) or vehicle
induced by PE or not. cAMP level exposed to only
chuanxiongzine (10
 4moll
 1), vehicle, PE and
chuanxiongzine, and PE and vehicle was 1.21±0.29,
1.17±0.14, 1.09±0.32 and 1.06±0.28pmolmg
 1 and
the cGMP level exposed to them was 0.26±0.07,
0.23±0.09, 0.19±0.06 and 0.15±0.03pmolmg
 1,
respectively. There were no significant differences
o nc A M Pa n dc G M Pi nt h eg r o u p sa b o v e( P40.05).
Conversely, in the presence of forskolin and sodium
nitroprusside, chuanxiongzine increased the level of
cAMP(11.47±1.48pmolmg
 1,Po0.05whencompared
with the vehicle: 4.61±0.30pmolmg
 1; Figure 3a) and
cGMP (0.93±0.12pmoll
 1, Po0.05 when compared
with the vehicle: 0.68±0.11pmolmg
 1; Figure 3b).
Chuanxiongzine-induced rise of ICP in vivo
The response profile for chuanxiongzine in the
organ bath studies formed the rationale for its
further in vivo evaluation. In the rabbits, the
recorded baseline ICP was 13.9±4.2mmHg and
the mean SAP was 61.6±7.4mmHg. Intracavernosal
injection of normal saline induced a transient rise
in ICP in a volume-dependent manner. However,
the rising ICP soon returned to the resting level
within 1–2min. In the chuanxiongzine group, the
erectile responses were facilitated after cumulative
doses were intracavernosally administered in seven
rabbits. Chuanxiongzine increased ICP during erectile
responses up to 6.5–25.8mmHg when compared
with the group intracavernosal administration of
normal saline. During the injection, the SAP, MBp
and HR were unchanged. Intracavernosal adminis-
tration of chuanxiongzine with cumulative doses
(0.5, 1, 2 and 5mgkg
 1) caused a dose-dependent
increase in the ICP. The ICP rose from the basal
value to 19.1±3.7, 24.8±2.1, 30.2±4.8 and 39.7±
6.1mmHg, respectively. DT ranged from 8.5±2.8 to
22.9±7.3min (Figure 4). In three rabbits, a transient
episode of slight decrease of SAP was recorded after
the intracavernosal administration of high dose
of chuanxiongzine (5mgkg
 1). However, there was
no significant difference (P40.05). At any doses of









































 1), ODQ (1-H-[1,2,4] oxadiazolo [4,3-a] quinoxalin-1-
one, 10
 4moll
 1) and removal of endothelium on chuanxiong-
zine-induced relaxation of isolated corpus cavernosum strips
precontracted with phenylephrine (10
 5moll
 1). Symbols are













































































Chuanxiongzine (n=8) Control (n=8)
cGMP
Figure 3 (a) Effects of chuanxiongzine on the levels of cyclic
adenosine monophosphate (cAMP) in isolated corpus caverno-
sum strips precontracted with phenylephrine and pretreated with
forskolin and sodium nitroprusside. *Po0.05, when compared
with control. (b) Effects of chuanxiongzine on the levels of cyclic
guanosine monophosphate (cGMP) in isolated corpus caverno-
sum strips precontracted with PE and pretreated with forskolin
and sodium nitroprusside. *Po0.05, when compared with
control.
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during the injections.
Discussion
It has been proved that NO–cGMP axis and/or cAMP
signal transduction pathway have an important role
in mediating penile erection.
7,32,33 Agents that
increase levels of cGMP and/or cAMP could be
expected to enhance relaxation of corpus cavernosal
smooth muscle and thereby may be applicable for
the treatment of ED. Phosphodiesterase inhibitor is
one such classical drug that prevents the hydrolysis
of cGMP and/or cAMP and then elevates the
levels of these cyclic nucleotides. There are
several Chinese traditional herbals that relax the
corpus cavernosum to contribute to penile erectile
activity through enhancing the intracellular cyclic
nucleotides.
29,34–38 As a vasodilator, chuanxiong-
zine has been clinically used for the treatment
of various vascular diseases such as pulmonary
hypertension and coronary artery diseases in
China.
25,39 It has been shown to exert relaxant
effects on vascular smooth muscle because of
multiple actions such as affecting cellular Ca
2þ
homeostasis as a nonspecific calcium antagonist,
enhancing NO synthesis or inhibiting the activity
of phosphodiesterase leading to the subsequent
enhancement of cAMP concentration.
40–43 This
study was determined to explore its mecha-
nism underlying the relaxatory actions of chuan-
xiongzine on corpus cavernosal smooth muscle.
Our studies have shown that chuanxiongzine was
effective in relaxing isolated rabbit cavernosal strips
and depressing the response to PE in a concentra-
tion-dependent manner in vitro. In the endothelium-
deprived group, the response of cavernosal strips to
chuanxiongzine was not affected. Therefore, an
endothelium-dependent mechanism was excluded.
Chuanxiongzine has a potent relaxant activity on
cavernosal strips, which was endothelium indepen-
dent. L-NAME did not execute significant effects
on chuanxiongzine-induced relaxation in them, but
ODQ caused a significant shift to the right of this
relationship. Thus, we speculated that the relaxant
effect of chuanxiongzine on cavernosal strips might
not be related to the enhancement of activation of
NO synthase, guanylyl cyclase and adenylyl cyclase.
It was inferred that its relaxant properties might be
attributable to other pharmacological actions such as
prevention of cyclic nucleotide degradation. This
experiment showed that chuanxiongzine caused a
significant rise in the levels of cGMP and cAMP in
isolated corpus cavernosum strips pretreated with
the activator of adenylyl cyclase forskolin and the
source of NO sodium nitroprusside.
In an in vivo study, the cumulative doses of
chuanxiongzine (0.5–5mgkg
 1) from low (0.5mgkg
 1)
to high (5mgkg
 1) doses were intracavernosally
injected. In anesthetized rabbits, erectile responses
were significantly facilitated after cumulative doses
(0.5, 1, 2 and 5mgkg
 1) of chuanxiongzine were
administered and induced a dose-dependent rise
in the ICP. The maximal ICP was raised up to
25.8±5.9mmHg and DT lasted 22.9±7.3min
when a high dose of chuanxiongzine (5mgkg
 1)
was intracavernosally injected. It has been found
that optimal dosages of chuanxiongzine were
1–2mgkg
 1, which resulted in the most efficacious
rise of ICP without significant changes in SAP and
HR. Although three of seven rabbits showed a
transient episode of slight decrease in SAP simul-
taneously after the 5mgkg
 1 chuanxiongzine intra-
cavernosal administration during the injections, the
SAP soon returned to the normal level. These results
indicated that even if a high dosage (5mgkg
 1)o f
chuanxiongzine was intracavernosally injected, it
did not lead to any significant hypotension and any
other systemic hemodynamic changes. The possible
reason is that chuanxiongzine was absorbed into
blood slowly after it was injected into the corpus
cavernosum. It is therefore reasonable to assume
that chuanxiongzine has the potential to be used as
a drug for intracavernous injection therapy for ED
that was not influenced by any systemic hemo-
dynamic changes. Jian and Hao
44 reported that the
intracavernous injection of phentolamine, papaver-
ine in combination with chuanxiongzine (40mg)
could persist longer in erection duration and
reinforce harder than phentolamine and papaverine
alone in the patients of ED. In China, chuanxiong-
zine has been clinically used to treat pulmonary
hypertension with the usual dosage (1–2mgkg
 1)
of intravenous administration. Zhang and Zhou
45,
Wang and Cheng
46 have confirmed that chuanxiong-
zine could decrease the tension and pressure of the
pulmonary artery through increasing cAMP and
0.8
Chuanxiongzine

























Figure 4 Chuanxiongzine-induced increase of ICP in rabbits.
Symbols are mean±s.e.m., ICP: intracavernous pressure, SAP:
systolic arterial pressure.
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xiongzine used in this study is compatible with the
usual clinical dosage used for pulmonary hyper-
tension. In a word, the usual clinical dosage of
chuanxiongzine resulted in a dose-dependent rise
in ICP after intracavernosal administration without
significant impact on systemic hemodynamic
changes.
In conclusion, this study has shown that chuan-
xiongzine can relax isolated corpus cavernosum
strips of rabbits in vitro and increase ICP of rabbits
in vivo, which is neither endothelium dependent
nor NO dependent, but may be partly mediated
by the inhibition of cAMP phosphodiesterase or
cGMP phosphodiesterase. Its relaxant properties
were attributed to the increase in intracellular cyclic
nucleotide levels, which were not due to the acti-
vation of NO synthesis, guanylyl cyclase or adenylyl
cyclase, but to the prevention of cyclic nucleotide
degradation. Further studies are needed to investi-
gate whether chuanxiongzine induced relaxation by
inhibiting some of those phosphodiesterases, which
could increase cGMP and cAMP concentration.
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